Lars began by emphasizing the urgency of advancing biotechnology safely. I reassured him that this is possible, highlighting two key factors: aggressive private sector investment, federally funded basic research, and science-based regulation.
biotechnology safety
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
